CME Group (CME)Director sold ~$92K

~$92K

Approx. value · 300 sh @ $305.90

25K

Holds after · shares reported

Traded

Feb 20, 2026

Filed

Feb 20, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 18, 2025CongressDisclosed sale of CME — reported range $1,001 - $15,000
2. Jan 9, 2026CongressDisclosed purchase of CME — reported range $1,001 - $15,000
3. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
4. Feb 6, 2026InsiderDirector sold ~$224K of CME shares in the open market
5. Feb 12, 2026Government · Federal Register noticeNotice of an Application of the Chicago Mercantile Exchange Inc. for an Exemption Pursuant to Section 36 of the Securities Exchange Act of 1934 and Request for Comment in Connection With the Opening Price Settlement Requirements of Rule 6h-1(b) Under the Securities Exchange Act of 1934 for Certain Cash-Settled Security Futures
6. Feb 20, 2026 · this disclosureInsiderDirector sold ~$92K of CME shares in the open market

What came next

1. Feb 23, 2026InsiderDirector sold ~$1.3M of CME shares in the open market
2. Mar 5, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
3. Mar 6, 2026InsiderDirector sold ~$320K of CME shares in the open market
4. Mar 12, 2026Insider · Their largest sale since 2013Officer sold ~$1.59M of CME shares in the open market
5. Mar 17, 2026InsiderOfficer sold ~$1.03M of CME shares in the open market
6. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
7. Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
8. Apr 22, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
9. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
10. May 15, 2026Insider · 1 personInsiders: 2 sales (~$10.4M)
11. May 18, 2026Insider · Their largest sale since 2007Officer sold ~$1.75M of CME shares in the open market
12. Jun 12, 2026Government · Federal Register proposed rulePrediction Markets; Public Interest Determinations
13. Jun 16, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 17, 2026, CME Group Inc. (the “Company”) announced that Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman, and Lynne C. Fitzpatrick, the Company’s current President and Chief Financial Officer, will succeed Mr. Duffy as the Company’s Chief Executive Officer (the “Leadership Transition”).”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for CME Group

For CME Group, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 60 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CME page.

Other recent filings by Martin J Gepsman, Director

• SEC Form 4 at CME Group (CME)May 19, 2025
• SEC Form 4 at CME Group (CME)Nov 5, 2024

The full history of Martin J Gepsman, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at CME Group

• SEC Form 144Sep 16, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 144Sep 14, 2026
• SEC Form 4Sep 11, 2026
• SEC Form 4Sep 11, 2026
• SEC Form 144Sep 10, 2026

Everything OQRO holds on this company is on its CME page.